{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T00:32:08Z","timestamp":1778286728510,"version":"3.51.4"},"reference-count":50,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2005,3,11]],"date-time":"2005-03-11T00:00:00Z","timestamp":1110499200000},"content-version":"vor","delay-in-days":100,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Transplant Infectious Dis"],"published-print":{"date-parts":[[2004,12]]},"abstract":"<jats:p><jats:bold>Abstract: Background: <\/jats:bold> Epstein\u2013Barr virus (EBV) is recognised as one of the causative agents for most cases of post\u2010transplant lymphoproliferative disease (PTLD). Elevated levels of EBV DNA are known to be associated with the onset of PTLD, but little information is available regarding how EBV loads change with time in asymptomatic transplant recipients following transplantation. Our aims were to study the trend of EBV loads in renal (RTx), hepatic, and cardiothoracic transplant recipients and to compare their EBV loads with other healthy and patient controls.<\/jats:p><jats:p><jats:bold>Methods: <\/jats:bold> A prospective study was performed using a real\u2010time TaqMan polymerase chain reaction technique to measure EBV DNA loads from three types of organ transplant recipients and haemodialysis patients (HD). Their results were then compared with those from the healthy controls (HC); monospot test negative (MN\u2212) and infectious mononucleosis positive (IM+) patients; patients who were previously treated for PTLD (pPTLD); those who were currently diagnosed to have PTLD (PTLD+); and patients who had a stable renal, hepatic, or cardiothoracic graft for more than a year.<\/jats:p><jats:p><jats:bold>Results: <\/jats:bold> Post\u2010transplant EBV loads were significantly higher than the pre\u2010transplant levels. Asymptomatic transplant recipients were differentiated from the PTLD+group at 600 genome copies of EBV\/\u03bcg DNA, and from IM+group at 100 genome copies. Both HC and MN\u2212 groups had significantly lower EBV loads than the three transplant groups. The dynamic change of EBV loads in RTx was greater in the first post\u2010transplant month when compared with the HD group. All transplant recipients had transient rises of EBV loads whereas EBV load continued to rise in one suspected PTLD patient.<\/jats:p><jats:p><jats:bold>Conclusions: <\/jats:bold> Asymptomatic transplant recipients had higher baseline post\u2010transplant EBV levels than the non\u2010transplant and MN\u2212 groups. The rising post\u2010transplant EBV load in these transplant recipients did not seem to be sustained for longer than 2 weeks. However, in a PTLD+patient the rising EBV load continued over a period of 4 weeks. Hence, the dynamic pattern of EBV loads is more important than absolute EBV DNA measurements alone in identifying those who might go on to develop PTLD.<\/jats:p>","DOI":"10.1111\/j.1399-3062.2004.00073.x","type":"journal-article","created":{"date-parts":[[2005,3,11]],"date-time":"2005-03-11T11:45:51Z","timestamp":1110541551000},"page":"156-164","source":"Crossref","is-referenced-by-count":15,"title":["Dynamic EBV gene loads in renal, hepatic, and cardiothoracic transplant recipients as determined by real\u2010time PCR light cycler"],"prefix":"10.1111","volume":"6","author":[{"given":"E.","family":"Leung","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.K.","family":"Shenton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Green","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Jackson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.K.","family":"Gould","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Yap","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Talbot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2005,3,11]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1995.tb08904.x"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V92.5.1549"},{"key":"e_1_2_6_4_2","doi-asserted-by":"crossref","first-page":"2925","DOI":"10.1182\/blood.V91.8.2925.2925_2925_2934","article-title":"Epstein\u2013Barr virus (EBV)\u2010specific cytotoxic T lymphocytes for the treatment of patients with EBV\u2010positive relapsed Hodgkin's disease","volume":"91","author":"Roskrow MA","year":"1998","journal-title":"Blood"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V95.4.1502.004k40_1502_1505"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1093\/qjmed\/90.8.497"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199806113382407"},{"key":"e_1_2_6_8_2","first-page":"381","article-title":"Classification of Epstein\u2013Barr virus\u2010associated posttransplant lymphoproliferative diseases","volume":"46","author":"Hanto DW.","year":"1995","journal-title":"implications for understanding their pathogenesis and developing rational treatment strategies"},{"key":"e_1_2_6_9_2","first-page":"3137","article-title":"Anti\u2010B\u2010cell monoclonal antibody treatment of severe posttransplant B\u2010lymphoproliferative disorders","volume":"92","author":"Benkerrou M","year":"1998","journal-title":"prognostic factors and long-term outcome"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V91.10.3654"},{"key":"e_1_2_6_11_2","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1128\/jcm.33.7.1765-1768.1995","article-title":"Detection and quantification of virus DNA in plasma of patients with Epstein\u2013Barr virus\u2010associated diseases","volume":"33","author":"Yamamoto M","year":"1995","journal-title":"J Clin Microbiol"},{"key":"e_1_2_6_12_2","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1128\/jcm.35.6.1612-1615.1997","article-title":"Use of quantitative competitive PCR to measure Epstein\u2013Barr virus genome load in the peripheral blood of pediatric transplant patients with lymphoproliferative disorders","volume":"35","author":"Rowe DT","year":"1997","journal-title":"J Clin Microbiol"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.37.4.1113-1116.1999"},{"key":"e_1_2_6_14_2","first-page":"807","article-title":"Epstein\u2013Barr virus (EBV) load in bone marrow transplant recipients at risk to develop posttransplant lymphoproliferative disease","volume":"95","author":"Gustafsson A","year":"2000","journal-title":"prophylactic infusion of EBV-cytotoxic T cells"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-199812270-00012"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.190.4.567"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1086\/315828"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-199812270-00006"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-200008270-00010"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0215(19990820)84:4<442::AID-IJC20>3.0.CO;2-J"},{"key":"e_1_2_6_21_2","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1128\/JCM.37.1.132-136.1999","article-title":"Quantitative analysis of Epstein\u2013Barr virus load by using a real\u2010time PCR assay","volume":"37","author":"Kimura H","year":"1999","journal-title":"J Clin Microbiol"},{"key":"e_1_2_6_22_2","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1128\/JCM.38.2.712-715.2000","article-title":"Development of a real\u2010time quantitative assay for detection of Epstein\u2013Barr virus","volume":"38","author":"Niesters HG","year":"2000","journal-title":"J Clin Microbiol"},{"key":"e_1_2_6_23_2","first-page":"1188","article-title":"Quantitative analysis of cell\u2010free Epstein\u2013Barr virus DNA in plasma of patients with nasopharyngeal carcinoma","volume":"59","author":"Lo YM","year":"1999","journal-title":"Cancer Res"},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.1034\/j.1399-0012.2000.140406.x"},{"key":"e_1_2_6_25_2","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1182\/blood.V71.5.1234.1234","article-title":"Epstein\u2013Barr virus associated B cell lymphoproliferative disorders following bone marrow transplantation","volume":"71","author":"Shapiro RS","year":"1988","journal-title":"Blood"},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V97.5.1165"},{"key":"e_1_2_6_27_2","first-page":"1211","article-title":"Towards standardization of Epstein\u2013Barr virus DNA load monitoring","volume":"39","author":"Stevens SJ","year":"2001","journal-title":"unfractionated whole blood as preferred clinical specimen"},{"key":"e_1_2_6_28_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V98.4.972"},{"key":"e_1_2_6_29_2","doi-asserted-by":"publisher","DOI":"10.1097\/00075200-199909000-00018"},{"key":"e_1_2_6_30_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2001.02789.x"},{"key":"e_1_2_6_31_2","first-page":"4055","article-title":"Characterization of Epstein\u2013Barr virus\u2010infected B cells in patients with posttransplant lymphoproliferative disease","volume":"96","author":"Yang J","year":"2000","journal-title":"disappearance after rituximab therapy does not predict clinical response"},{"key":"e_1_2_6_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-1759(02)00333-2"},{"key":"e_1_2_6_33_2","first-page":"768","article-title":"Quantitative analysis of fetal DNA in maternal plasma and serum","volume":"62","author":"Lo YM","year":"1998","journal-title":"implications for noninvasive prenatal diagnosis"},{"key":"e_1_2_6_34_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.88.16.7276"},{"key":"e_1_2_6_35_2","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/21.16.3761"},{"key":"e_1_2_6_36_2","doi-asserted-by":"publisher","DOI":"10.1101\/gr.4.6.357"},{"key":"e_1_2_6_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-1759(01)00489-6"},{"key":"e_1_2_6_38_2","volume-title":"Nonprametric Statistics for Health Care Research: Statistics for Small Samples and Unusual Distributions","author":"Pett MA.","year":"1997"},{"key":"e_1_2_6_39_2","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1182\/blood.V84.3.972.972","article-title":"Increased levels of circulating Epstein\u2013Barr virus (EBV)\u2010infected lymphocytes and decreased EBV nuclear antigen antibody responses are associated with the development of posttransplant lymphoproliferative disease in solid organ transplant recipients","volume":"84","author":"Riddler SA","year":"1994","journal-title":"Blood"},{"key":"e_1_2_6_40_2","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1128\/JCM.38.2.613-619.2000","article-title":"High levels of Epstein\u2013Barr virus DNA in blood of solid\u2010organ transplant recipients and their value in predicting posttransplant lymphoproliferative disorders","volume":"38","author":"Baldanti F","year":"2000","journal-title":"J Clin Microbiol"},{"key":"e_1_2_6_41_2","first-page":"76","article-title":"Epstein\u2013Barr virus (EBV) reactivation in allogeneic stem\u2010cell transplantation","volume":"77","author":"Clave E","year":"2004","journal-title":"relationship between viral load, EBV-specific T-cell reconstitution and rituximab therapy"},{"key":"e_1_2_6_42_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-12-4287"},{"key":"e_1_2_6_43_2","first-page":"1012","article-title":"Patients at risk for development of posttransplant lymphoproliferative disorder","volume":"72","author":"Wagner HJ","year":"2001","journal-title":"plasma versus peripheral blood mononuclear cells as material for quantification of Epstein\u2013Barr viral load by using real-time quantitative polymerase chain reaction"},{"key":"e_1_2_6_44_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-199509270-00005"},{"key":"e_1_2_6_45_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-200003150-00048"},{"key":"e_1_2_6_46_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.37.9.2852-2857.1999"},{"key":"e_1_2_6_47_2","doi-asserted-by":"publisher","DOI":"10.1086\/315495"},{"key":"e_1_2_6_48_2","first-page":"95","article-title":"Post\u2010transplant lymphoproliferative disorder","volume":"3","author":"Webber SA.","year":"1999","journal-title":"a preventable complication of solid organ transplantation?"},{"key":"e_1_2_6_49_2","first-page":"194","article-title":"Persistent Epstein\u2013Barr virus infection","volume":"74","author":"Hopwood PA","year":"2002","journal-title":"unrestricted latent and lytic viral gene expression in healthy immunosuppressed transplant recipients"},{"key":"e_1_2_6_50_2","first-page":"79","article-title":"Epstein\u2013Barr virus load monitoring","volume":"3","author":"Rowe D","year":"2001","journal-title":"its role in the prevention and management of post-transplant lymphoproliferative disease"},{"key":"e_1_2_6_51_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-200205270-00014"}],"container-title":["Transplant Infectious Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1399-3062.2004.00073.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1399-3062.2004.00073.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,9]],"date-time":"2023-10-09T17:16:22Z","timestamp":1696871782000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1399-3062.2004.00073.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,12]]},"references-count":50,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2004,12]]}},"alternative-id":["10.1111\/j.1399-3062.2004.00073.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1399-3062.2004.00073.x","archive":["Portico"],"relation":{},"ISSN":["1398-2273","1399-3062"],"issn-type":[{"value":"1398-2273","type":"print"},{"value":"1399-3062","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,12]]}}}